Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00049231 · ClinicalTrials.gov registry record · NA
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
A NA study of Cervical Cancer, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 5
- Study locations
NCT00049231: Completed NA study of Cervical Cancer, sponsored by Gynecologic Oncology Group.
NCT00049231 is a NA study of Cervical Cancer that has completed, run by Gynecologic Oncology Group. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00049231, a NA study of Cervical Cancer, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 5
- Study locations
Study Summary
RATIONALE: Knowing the level of oxygen in tumor tissue may help predict the effectiveness of anticancer therapy. EF5 may be effective in measuring oxygen in tumor tissue and helping to predict the effectiveness of anticancer therapy. PURPOSE: Diagnostic trial to study the effectiveness of EF5 in detecting tumor hypoxia in patients who have stage IIB, stage IIIB, or stage IVA cervical cancer.
Conditions Studied
Interventions
- PROCEDURE biopsy
- OTHER immunohistochemistry staining method
- DRUG EF5
Study Locations (5)
Oklahoma
- Oklahoma University Medical Center - Oklahoma City
- Cancer Care Associates - Midtown Tulsa - Tulsa
Arkansas
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences - Little Rock
Colorado
- Colorado Gynecologic Oncology Group P.C. - Denver
Missouri
- Ellis Fischel Cancer Center at University of Missouri - Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-06 |
| Est. Completion | 2005-08 |
| Phase | NA |
What the finished NCT00049231 record still lists
NCT00049231 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 3 interventions - of which biopsy is the first listed.
NCT00049231 lists 5 locations in 4 states (Oklahoma, Arkansas, Colorado).
Frequently Asked Questions
What is clinical trial NCT00049231 about?
NCT00049231 is a clinical study titled "EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer". RATIONALE: Knowing the level of oxygen in tumor tissue may help predict the effectiveness of anticancer therapy. EF5 may be effective in measuring oxygen in tumor tissue and helping to predict the effectiveness of anticancer therapy. PURPOSE: Diagnostic trial to study the effectiveness of EF5 in de...
What is the current status of trial NCT00049231?
This trial is currently completed. It is a NA study. The study started on 2003-06. Estimated completion is 2005-08.
What conditions does trial NCT00049231 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00049231?
The interventions under investigation include: biopsy (PROCEDURE), immunohistochemistry staining method (OTHER), EF5 (DRUG).
Who is sponsoring clinical trial NCT00049231?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00049231 being conducted?
This trial has 5 study locations across Arkansas, Colorado, Missouri, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia